HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bart L Haagmans Selected Research

Bart L Haagmans Research Topics

Disease

53Infections
05/2024 - 01/2002
28COVID-19
05/2024 - 01/2020
12Virus Diseases (Viral Diseases)
03/2024 - 11/2003
9Chronic Hepatitis C
01/2014 - 06/2003
7Coronavirus Infections
01/2023 - 10/2014
4Chronic Hepatitis B
01/2014 - 09/2006
3Inflammation (Inflammations)
12/2023 - 02/2010
2Pneumonia (Pneumonitis)
12/2022 - 01/2021
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 06/2017
2Communicable Diseases (Infectious Diseases)
01/2021 - 01/2020
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 08/2007
2Hepatitis
11/2014 - 08/2003
1Thrombocytopenia (Thrombopenia)
12/2023
1Leprosy (Hansen's Disease)
12/2023
1Vaccinia
01/2023
1Smallpox (Variola)
01/2023
1Disease Progression
12/2022
1Zoonoses
06/2022
1Hyperplasia
01/2022
1Critical Illness (Critically Ill)
01/2022
1Asymptomatic Infections
12/2021
1Weight Loss (Weight Reduction)
01/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021
1Emerging Communicable Diseases (Emerging Infectious Diseases)
05/2020
1Cytokine Release Syndrome
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2018
1Acute Disease
01/2018
1Viremia
05/2016
1Multiple Sclerosis
02/2016

Drug/Important Bio-Agent (IBA)

22VaccinesIBA
05/2024 - 04/2011
15Neutralizing AntibodiesIBA
05/2024 - 03/2006
14Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2002
14AntibodiesIBA
01/2023 - 03/2013
13Antiviral Agents (Antivirals)IBA
12/2023 - 11/2003
10Monoclonal AntibodiesIBA
03/2024 - 06/2004
10InterferonsIBA
01/2014 - 06/2003
7Ribavirin (Virazole)FDA LinkGeneric
01/2013 - 06/2003
5RNA (Ribonucleic Acid)IBA
01/2019 - 02/2011
4Viral RNAIBA
11/2021 - 08/2013
3Immunoglobulin G (IgG)IBA
01/2022 - 04/2004
3LipopeptidesIBA
01/2022 - 11/2020
3AntigensIBA
01/2021 - 03/2004
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2018 - 08/2013
3Interferon-alpha (Interferon Alfa)IBA
01/2007 - 06/2003
2N-(2-cyanoethylene)urea (BA 1)IBA
05/2024 - 12/2022
2Messenger RNA (mRNA)IBA
12/2023 - 01/2018
2BNT162 VaccineIBA
12/2023 - 01/2021
2remdesivirIBA
12/2023 - 07/2022
2EpitopesIBA
01/2022 - 01/2020
2Viral AntigensIBA
01/2022 - 03/2019
2Viral ProteinsIBA
01/2021 - 08/2013
2Staphylococcal Protein A (Protein A)IBA
05/2020 - 10/2014
2ChemokinesIBA
01/2013 - 08/2007
2CytokinesIBA
01/2013 - 08/2007
2Hepatitis B e AntigensIBA
01/2007 - 09/2006
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2024
1Cidofovir (Vistide)FDA Link
01/2024
1Ad26COVS1IBA
12/2023
1Platelet Factor 4IBA
12/2023
1COVID-19 VaccinesIBA
12/2023
1AutoantibodiesIBA
12/2023
1ChAdOx1 nCoV-19IBA
12/2023
12019-nCoV Vaccine mRNA-1273IBA
12/2023
1Clofazimine (Lamprene)FDA Link
12/2023
1Therapeutic UsesIBA
12/2023
1NucleoproteinsIBA
01/2023
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2023
1Smallpox Vaccine (Vaccine, Smallpox)FDA Link
01/2023
1FucoseIBA
01/2023
1MucinsIBA
01/2023
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2023
1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2023
1Polysaccharides (Glycans)IBA
01/2023
1Synthetic Vaccines (Recombinant Vaccines)IBA
01/2023
1molnupiravirIBA
07/2022
1Immune Sera (Antisera)IBA
01/2022
1NanovaccinesIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Protein Subunit VaccinesIBA
05/2020
1Subunit VaccinesIBA
05/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Broadly Neutralizing AntibodiesIBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1Inactivated VaccinesIBA
01/2020
1LigandsIBA
01/2019
1Neuraminidase (Sialidase)IBA
01/2019
1Cell Surface ReceptorsIBA
01/2018
1GoldIBA
01/2018
1Edetic Acid (EDTA)FDA Link
05/2016
1AutoantigensIBA
02/2016
1Cardiac GlycosidesIBA
04/2015
1src-Family KinasesIBA
04/2015
1bufalinIBA
04/2015
1Ouabain (G Strophanthin)IBA
04/2015

Therapy/Procedure

12Therapeutics
01/2022 - 06/2003
2Intranasal Administration
01/2021 - 11/2020
1Drug Therapy (Chemotherapy)
01/2024
1Artificial Respiration (Mechanical Ventilation)
01/2020
1Length of Stay
01/2017
1Hand Hygiene
01/2017